According to the research report published by Market IntelliX, the global market for Celecoxib API should grow from US$ 56 million in 2022 to US$ 82 million by 2029, with a CAGR of 4.9% for the period of 2023-2029.

Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.

Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.

This report studies and analyses global Celecoxib API status and future trends, helps the client to determine the Celecoxib API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Celecoxib API, and provides market size (in Kg & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Celecoxib API market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Kg)

(2) Global Celecoxib API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Kg)

(3) China Celecoxib API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Kg)

(4) Global Celecoxib API key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Celecoxib API key producing regions, capacity, production, and year over year growth

(6) Celecoxib API industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Pfizer

Teva Pharmaceuticals

Viatris(Mylan)

ScinoPharm

Jiangxi Synergy

Jiangsu Hengrui Medicine

Jiangsu Chiatai Qingjiang

Hisun Pharmaceutical Nantong

Aurobindo Pharma

Punjab Chemicals

Market segment by Type, covers

Standard grade Celecoxib API

Micronized Celecoxib API

Market segment by Application, can be divided into

Pharmaceutical

Laboratory

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Celecoxib API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Celecoxib API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Celecoxib API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Celecoxib API, percent & CAGR, 2018-2029

Chapter 5: Celecoxib API industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Celecoxib API Definition

1.2 Global Celecoxib API Market Size and Forecast

1.2.1 By Consumption Value, Global Celecoxib API Market Size，2018-2029

1.2.2 By Sales Quantity, Global Celecoxib API Market Size，2018-2029

1.2.3 Global Celecoxib API Average Selling Price (ASP)，2018-2029

1.3 China Celecoxib API Market Size and Forecast

1.3.1 By Consumption Value, China Celecoxib API Market Size，2018-2029

1.3.2 By Sales Quantity, China Celecoxib API Market Size，2018-2029

1.3.3 China Celecoxib API Average Selling Price (ASP)， 2018-2029

1.4 Share of China Celecoxib API Market with Respect to the Global Market

1.4.1 By Consumption Value, China Celecoxib API Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Celecoxib API Market Share in Global, 2018-2029

1.4.3 Celecoxib API Market Size: China VS Global, 2018-2029

1.5 Celecoxib API Market Dynamics

1.5.1 Celecoxib API Market Drivers

1.5.2 Celecoxib API Market Restraints

1.5.3 Celecoxib API Industry Trends

1.5.4 Celecoxib API Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Celecoxib API, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Celecoxib API, Global Market Share by Company, 2018-2023

2.3 Celecoxib API Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Celecoxib API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Celecoxib API Concentration Ratio

2.6 Global Celecoxib API Mergers & Acquisitions, Expansion Plans

2.7 Global Celecoxib API Manufacturers Product Type

2.8 Head Office and Celecoxib API Production Site of Key Manufacturer

2.9 Celecoxib API Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Celecoxib API, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Celecoxib API, China Market Share by Company, 2018-2023

3.3 China Celecoxib API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Celecoxib API Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Celecoxib API Capacity by Region

4.3 Global Celecoxib API Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Celecoxib API Production by Region, 2018-2029

4.5 Global Celecoxib API Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Celecoxib API Industry Chain

5.2 Celecoxib API Upstream Analysis

5.2.1 Celecoxib API Core Raw Materials

5.2.2 Main Manufacturers of Celecoxib API Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Celecoxib API Production Mode

5.6 Celecoxib API Procurement Model

5.7 Celecoxib API Industry Sales Model and Sales Channels

5.7.1 Celecoxib API Sales Model

5.7.2 Celecoxib API Typical Distributors

6 Sights by Type

6.1 Celecoxib API Classification

6.1.1 Standard grade Celecoxib API

6.1.2 Micronized Celecoxib API

6.2 By Type, Global Celecoxib API Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Celecoxib API Consumption Value, 2018-2029

6.4 By Type, Global Celecoxib API Sales Quantity, 2018-2029

6.5 By Type, Global Celecoxib API Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Celecoxib API Segment by Application

7.1.1 Pharmaceutical

7.1.2 Laboratory

7.2 By Application, Global Celecoxib API Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Celecoxib API Consumption Value, 2018-2029

7.4 By Application, Global Celecoxib API Sales Quantity, 2018-2029

7.5 By Application, Global Celecoxib API Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Celecoxib API Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Celecoxib API Consumption Value, 2018-2029

8.3 By Region, Global Celecoxib API Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Celecoxib API & Forecasts, 2018-2029

8.4.2 By Country, North America Celecoxib API Market Size Market Share

8.5 Europe

8.5.1 Europe Celecoxib API Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Celecoxib API Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Celecoxib API Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Celecoxib API Market Size Market Share

8.7 South America

8.7.1 South America Celecoxib API Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Celecoxib API Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Celecoxib API Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Celecoxib API Consumption Value, 2018-2029

9.3 By Country, Global Celecoxib API Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Celecoxib API Market Size, 2018-2029

9.4.2 By Type, U.S. Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Celecoxib API Market Size, 2018-2029

9.5.2 By Type, Europe Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Celecoxib API Market Size, 2018-2029

9.6.2 By Type, China Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Celecoxib API Market Size, 2018-2029

9.7.2 By Type, Japan Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Celecoxib API Market Size, 2018-2029

9.8.2 By Type, South Korea Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Celecoxib API Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Celecoxib API Market Size, 2018-2029

9.10.2 By Type, India Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Celecoxib API Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Celecoxib API Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Celecoxib API Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Pfizer

10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position

10.1.2 Pfizer Celecoxib API Models, Specifications, and Application

10.1.3 Pfizer Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Pfizer Company Profile and Main Business

10.1.5 Pfizer Recent Developments

10.2 Teva Pharmaceuticals

10.2.1 Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.2.2 Teva Pharmaceuticals Celecoxib API Models, Specifications, and Application

10.2.3 Teva Pharmaceuticals Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Teva Pharmaceuticals Company Profile and Main Business

10.2.5 Teva Pharmaceuticals Recent Developments

10.3 Viatris(Mylan)

10.3.1 Viatris(Mylan) Company Information, Head Office, Market Area, and Industry Position

10.3.2 Viatris(Mylan) Celecoxib API Models, Specifications, and Application

10.3.3 Viatris(Mylan) Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Viatris(Mylan) Company Profile and Main Business

10.3.5 Viatris(Mylan) Recent Developments

10.4 ScinoPharm

10.4.1 ScinoPharm Company Information, Head Office, Market Area, and Industry Position

10.4.2 ScinoPharm Celecoxib API Models, Specifications, and Application

10.4.3 ScinoPharm Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 ScinoPharm Company Profile and Main Business

10.4.5 ScinoPharm Recent Developments

10.5 Jiangxi Synergy

10.5.1 Jiangxi Synergy Company Information, Head Office, Market Area, and Industry Position

10.5.2 Jiangxi Synergy Celecoxib API Models, Specifications, and Application

10.5.3 Jiangxi Synergy Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Jiangxi Synergy Company Profile and Main Business

10.5.5 Jiangxi Synergy Recent Developments

10.6 Jiangsu Hengrui Medicine

10.6.1 Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position

10.6.2 Jiangsu Hengrui Medicine Celecoxib API Models, Specifications, and Application

10.6.3 Jiangsu Hengrui Medicine Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Jiangsu Hengrui Medicine Company Profile and Main Business

10.6.5 Jiangsu Hengrui Medicine Recent Developments

10.7 Jiangsu Chiatai Qingjiang

10.7.1 Jiangsu Chiatai Qingjiang Company Information, Head Office, Market Area, and Industry Position

10.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Models, Specifications, and Application

10.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Jiangsu Chiatai Qingjiang Company Profile and Main Business

10.7.5 Jiangsu Chiatai Qingjiang Recent Developments

10.8 Hisun Pharmaceutical Nantong

10.8.1 Hisun Pharmaceutical Nantong Company Information, Head Office, Market Area, and Industry Position

10.8.2 Hisun Pharmaceutical Nantong Celecoxib API Models, Specifications, and Application

10.8.3 Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Hisun Pharmaceutical Nantong Company Profile and Main Business

10.8.5 Hisun Pharmaceutical Nantong Recent Developments

10.9 Aurobindo Pharma

10.9.1 Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position

10.9.2 Aurobindo Pharma Celecoxib API Models, Specifications, and Application

10.9.3 Aurobindo Pharma Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Aurobindo Pharma Company Profile and Main Business

10.9.5 Aurobindo Pharma Recent Developments

10.10 Punjab Chemicals

10.10.1 Punjab Chemicals Company Information, Head Office, Market Area, and Industry Position

10.10.2 Punjab Chemicals Celecoxib API Models, Specifications, and Application

10.10.3 Punjab Chemicals Celecoxib API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Punjab Chemicals Company Profile and Main Business

10.10.5 Punjab Chemicals Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Celecoxib API Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Celecoxib API Market Restraints

Table 3. Celecoxib API Market Trends

Table 4. Celecoxib API Industry Policy

Table 5. Global Celecoxib API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Celecoxib API Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Celecoxib API Sales Quantity by Company, (2018-2023) & (Kg), Ranked Based on Sales in 2022

Table 8. Global Celecoxib API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Celecoxib API Average Selling Price (ASP) by Company, (2018-2023) & (US$/Kg)

Table 10. Global Celecoxib API Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Celecoxib API Mergers & Acquisitions, Expansion Plans

Table 12. Global Celecoxib API Manufacturers Product Type

Table 13. Head Office and Celecoxib API Production Site of Key Manufacturer

Table 14. Celecoxib API Capacity of Major Manufacturers and Future Plan

Table 15. China Celecoxib API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Celecoxib API Sales Quantity by Company, (2018-2023) & (Kg), Ranked Based on Sales in 2022

Table 17. China Celecoxib API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Celecoxib API Production & Forecast by Region, 2018 VS 2022 VS 2029, (Kg)

Table 19. Global Celecoxib API Production by Region, 2018-2023, (Kg)

Table 20. Global Celecoxib API Production Forecast by Region, 2024-2029, (Kg)

Table 21. Global Key Players of Celecoxib API Upstream (Raw Materials)

Table 22. Global Celecoxib API Typical Customers

Table 23. Celecoxib API Typical Distributors

Table 24. By Type, Global Celecoxib API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Celecoxib API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Celecoxib API Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Celecoxib API Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Celecoxib API Sales Quantity, 2018-2029, (Kg)

Table 29. By Country, Global Celecoxib API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Celecoxib API Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Celecoxib API Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Celecoxib API Sales Quantity, 2018-2029, (Kg)

Table 33. By Country, Global Celecoxib API Sales Quantity Market Share, 2018-2029

Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 35. Pfizer Celecoxib API Models, Specifications, and Application

Table 36. Pfizer Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 37. Pfizer Company Profile and Main Business

Table 38. Pfizer Recent Developments

Table 39. Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 40. Teva Pharmaceuticals Celecoxib API Models, Specifications, and Application

Table 41. Teva Pharmaceuticals Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 42. Teva Pharmaceuticals Company Profile and Main Business

Table 43. Teva Pharmaceuticals Recent Developments

Table 44. Viatris(Mylan) Company Information, Head Office, Market Area, and Industry Position

Table 45. Viatris(Mylan) Celecoxib API Models, Specifications, and Application

Table 46. Viatris(Mylan) Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 47. Viatris(Mylan) Company Profile and Main Business

Table 48. Viatris(Mylan) Recent Developments

Table 49. ScinoPharm Company Information, Head Office, Market Area, and Industry Position

Table 50. ScinoPharm Celecoxib API Models, Specifications, and Application

Table 51. ScinoPharm Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 52. ScinoPharm Company Profile and Main Business

Table 53. ScinoPharm Recent Developments

Table 54. Jiangxi Synergy Company Information, Head Office, Market Area, and Industry Position

Table 55. Jiangxi Synergy Celecoxib API Models, Specifications, and Application

Table 56. Jiangxi Synergy Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 57. Jiangxi Synergy Company Profile and Main Business

Table 58. Jiangxi Synergy Recent Developments

Table 59. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position

Table 60. Jiangsu Hengrui Medicine Celecoxib API Models, Specifications, and Application

Table 61. Jiangsu Hengrui Medicine Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 62. Jiangsu Hengrui Medicine Company Profile and Main Business

Table 63. Jiangsu Hengrui Medicine Recent Developments

Table 64. Jiangsu Chiatai Qingjiang Company Information, Head Office, Market Area, and Industry Position

Table 65. Jiangsu Chiatai Qingjiang Celecoxib API Models, Specifications, and Application

Table 66. Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 67. Jiangsu Chiatai Qingjiang Company Profile and Main Business

Table 68. Jiangsu Chiatai Qingjiang Recent Developments

Table 69. Hisun Pharmaceutical Nantong Company Information, Head Office, Market Area, and Industry Position

Table 70. Hisun Pharmaceutical Nantong Celecoxib API Models, Specifications, and Application

Table 71. Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 72. Hisun Pharmaceutical Nantong Company Profile and Main Business

Table 73. Hisun Pharmaceutical Nantong Recent Developments

Table 74. Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position

Table 75. Aurobindo Pharma Celecoxib API Models, Specifications, and Application

Table 76. Aurobindo Pharma Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 77. Aurobindo Pharma Company Profile and Main Business

Table 78. Aurobindo Pharma Recent Developments

Table 79. Punjab Chemicals Company Information, Head Office, Market Area, and Industry Position

Table 80. Punjab Chemicals Celecoxib API Models, Specifications, and Application

Table 81. Punjab Chemicals Celecoxib API Sales Quantity (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin, 2018-2023

Table 82. Punjab Chemicals Company Profile and Main Business

Table 83. Punjab Chemicals Recent Developments

List of Figures

Figure 1. Celecoxib API Picture

Figure 2. Global Celecoxib API Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Celecoxib API Sales Quantity, (Kg) & (2018-2029)

Figure 4. Global Celecoxib API Average Selling Price (ASP), (2018-2029) & (US$/Kg)

Figure 5. China Celecoxib API Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Celecoxib API Sales Quantity (Kg) & (2018-2029)

Figure 7. China Celecoxib API Average Selling Price (ASP), (US$/Kg) & (2018-2029)

Figure 8. By Consumption Value, China Celecoxib API Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Celecoxib API Market Share of Global, 2018-2029

Figure 10. Global Celecoxib API Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Celecoxib API Key Participants, Market Share, 2022

Figure 12. Global Celecoxib API Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Celecoxib API Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Celecoxib API Production Market Share & Forecast by Region, 2018-2029

Figure 15. Celecoxib API Industry Chain

Figure 16. Celecoxib API Procurement Model

Figure 17. Celecoxib API Sales Model

Figure 18. Celecoxib API Sales Channels, Direct Sales, and Distribution

Figure 19. Standard grade Celecoxib API

Figure 20. Micronized Celecoxib API

Figure 21. By Type, Global Celecoxib API Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Celecoxib API Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 24. By Type, Global Celecoxib API Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Celecoxib API Average Selling Price (ASP), 2018-2029, (US$/Kg)

Figure 26. Pharmaceutical

Figure 27. Laboratory

Figure 28. By Application, Global Celecoxib API Consumption Value, 2018-2029, US$ Million

Figure 29. By Application, Global Celecoxib API Consumption Value Market Share, 2018-2029

Figure 30. By Application, Global Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 31. By Application, Global Celecoxib API Sales Quantity Market Share, 2018-2029

Figure 32. By Application, Global Celecoxib API Average Selling Price (ASP), 2018-2029, (US$/Kg)

Figure 33. By Region, Global Celecoxib API Consumption Value Market Share, 2018-2029

Figure 34. By Region, Global Celecoxib API Sales Quantity Market Share, 2018-2029

Figure 35. North America Celecoxib API Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 36. By Country, North America Celecoxib API Consumption Value Market Share, 2022

Figure 37. Europe Celecoxib API Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, Europe Celecoxib API Consumption Value Market Share, 2022

Figure 39. Asia Pacific Celecoxib API Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country/Region, Asia Pacific Celecoxib API Consumption Value Market Share, 2022

Figure 41. South America Celecoxib API Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, South America Celecoxib API Consumption Value Market Share, 2022

Figure 43. Middle East & Africa Celecoxib API Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. U.S. Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 45. By Type, U.S. Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 46. By Application, U.S. Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 47. Europe Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 48. By Type, Europe Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, Europe Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 50. China Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 51. By Type, China Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, China Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 53. Japan Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 54. By Type, Japan Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Japan Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 56. South Korea Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 57. By Type, South Korea Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, South Korea Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 59. Southeast Asia Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 60. By Type, Southeast Asia Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Southeast Asia Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 62. India Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 63. By Type, India Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, India Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 65. Middle East & Africa Celecoxib API Sales Quantity, 2018-2029, (Kg)

Figure 66. By Type, Middle East & Africa Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Middle East & Africa Celecoxib API Sales Quantity Market Share, 2022 VS 2029

Figure 68. Research Methodology

Figure 69. Breakdown of Primary Interviews

Figure 70. Bottom-up and Top-down Approaches

Figure 71. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)